Westminster showcase for animal replacement research

   
   
25 Mar 2009 00:01:00.000

PA 81/09

Researchers from The University of Nottingham will be in Westminster today to talk to MPs about how innovative scientific advances could reduce the need for animal experimentation in the quest to find new treatments for the painful degenerative joint condition osteoarthritis.

 

Dr Ali Mobasheri, Associate Professor and Reader in Comparative Physiology at the University’s School of Veterinary Medicine and Science, and PhD postgraduate student Abigail Clutterbuck will showcase their research at a poster event organised by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) in the House of Lords.

 

Their work has been chosen as fine examples of research supporting the ethos of the centre, which provides a UK focus for the promotion, development and implementation of the 3Rs — replacement, refinement and reduction — in animal research and testing.

Click here for full story

Dr Mobasheri and Abigail both conduct research into developing our understanding of osteoarthritis, a painful and debilitating condition, which is the most common cause of joint disease in both humans and pets. It is hoped that by finding out more about how the condition progresses, new treatments and therapies can be developed to help relieve the symptoms of sufferers, which can include pain, inflammation and loss of mobility.

 

Current methods of studying the disease can involve artificially recreating the condition in animals used for experimentation. This can be done by injecting the joints of animals with substances that will cause inflammation or even by surgically severing the cruciate ligament of the knee, which is associated with the onset of the disease. The animal is often then put to sleep so that their tissues can be examined in greater detail.

 

The work of the Nottingham researchers is focused on using innovative new methods to obtain tissue from material discarded from food producing animals which are killed in abattoirs to go into the food chain.

 

Dr Mobasheri’s research centres on the development of tissue engineering for regenerative medicine. This involves taking bone marrow stem cells from animals to grow tissues in the lab on 3-D scaffolds. It is hoped that one day it could lead to revolutionary treatments for OA where the patient’s own stem cells could be used to grow new tissue to replace that which has been damaged by the disease.

 

Abigail’s research is looking at the identification of biomarkers — or early indicators — that could predict the onset of the disease in people and animals. This involves incubating cartilage from the fetlock joints of horses euthanized at abattoirs for reasons other than research, in the lab with a solution that allows cell survival along with a substance called Interleukin-1β — a protein that initiates and sustains inflammation — to simulate early stage OA.  Abigail then identifies and measures the proteins that are released from the cartilage in response to the stimulation.  It is hoped that by discovering proteins released from the cartilage in the lab, they may be eventually used as markers that can be measured in the blood or synovial fluid of patients in the early stages of the disease.  In this way, preventative measures could then be taken to reduce the progression of the disease.  The key important feature of Abigail’s research is that she does not create arthritis in live animals and no animal is put down for her research. All her material is taken from horse limbs that are surplus to the requirements of the meat industry.  By using this cartilage she can stimulate it to become osteoarthritic in the lab, thereby eliminating the need to surgically create arthritis in live animals.

 

Dr Mobasheri said: “Improved treatments for heart disease and cancer mean that we are now living longer than ever before and, as we become an ageing population, degenerative diseases such as osteoarthritis are going to place a huge burden on the NHS. Research into this area is vital if new therapies are to be discovered and by using techniques similar to those we are developing, hopefully that can be achieved while limiting unnecessary suffering to experimental animals.

 

“In the US scientists are extremely active in engaging with politicians through congress but in the UK we simply don’t have the same lobbying power. This event will be tremendously important in helping parliamentarians understand more about the latest advances in science and to help break down any worries or misconceptions they may have, particularly about the area of stem cell research.”

 

The event at the House of Lords is being held to mark the 50th anniversary of the 3Rs and participating researchers will show posters of their research work for each of the areas of replacement, refinement and reduction for the chance to win £3,000. It will be attended by MPs, Peers and other stakeholders, including Lord Sainsbury, the former Minister for Science and Innovation, who is among the sponsors.

 

— Ends —

 

Notes to editors:

The University of Nottingham is ranked in the UK's Top 10 and the World's Top 100 universities by the Shanghai Jiao Tong (SJTU) and Times Higher (THE) World University Rankings.

 

More than 90 per cent of research at The University of Nottingham is of international quality, according to RAE 2008, with almost 60 per cent of all research defined as ‘world-leading’ or ‘internationally excellent’. Research Fortnight analysis of RAE 2008 ranks the University 7th in the UK by research power. In 27 subject areas, the University features in the UK Top Ten, with 14 of those in the Top Five.

 

The University provides innovative and top quality teaching, undertakes world-changing research, and attracts talented staff and students from 150 nations. Described by The Times as Britain's ‘only truly global university’, it has invested continuously in award-winning campuses in the United Kingdom, China and Malaysia. Twice since 2003 its research and teaching academics have won Nobel Prizes. The University has won the Queen's Award for Enterprise in both 2006 (International Trade) and 2007 (Innovation – School of Pharmacy), and was named ‘Entrepreneurial University of the Year’ at the Times Higher Education Awards 2008.

 

Nottingham was designated as a Science City in 2005 in recognition of its rich scientific heritage, industrial base and role as a leading research centre. Nottingham has since embarked on a wide range of business, property, knowledge transfer and educational initiatives (www.science-city.co.uk) in order to build on its growing reputation as an international centre of scientific excellence. The University of Nottingham is a partner in Nottingham: the Science City.

Story credits

More information is available from Professor Ali Mobasheri on +44 (0)115 951 6449; 07790 824544; ali.mobasheri@nottingham.ac.uk

Emma Thorne Emma Thorne - Media Relations Manager

Email: emma.thorne@nottingham.ac.uk Phone: +44 (0)115 951 5793 Location: University Park

Additional resources

No additional resources for this article

Related articles

Anniversary symposium for scientific charity

Published Date
Wednesday 18th November 2009

Towards animal-free cancer research

Published Date
Thursday 12th November 2009

Media Relations - External Relations

The University of Nottingham
C Floor, Pope Building (Room C4)
University Park
Nottingham, NG7 2RD

telephone: +44 (0) 115 951 5798
email: communications@nottingham.ac.uk